InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

Current share price for ALC : $0.110 0.005 (4.35%)+

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$148 Initial Director's Interest Notice 15 Apr 2025 8:27AM $0.075 $0.110 risen by 46.67%
$148 Appointment of Non-Executive Director 15 Apr 2025 8:21AM $0.075 $0.110 risen by 46.67%
$148 Investor Roadshow Presentation 12 Mar 2025 8:18AM $0.076 $0.110 risen by 44.74%
$148 Coffee Microcaps Presentation 7 Mar 2025 8:21AM $0.083 $0.110 risen by 32.53%
$148 Change of Director's Interest Notice 4 Mar 2025 4:19PM $0.086 $0.110 risen by 27.91%
$148 Share Sale by Managing Director & CEO 4 Mar 2025 4:15PM $0.086 $0.110 risen by 27.91%
$148 Ceasing to be a substantial holder 27 Feb 2025 8:28PM $0.095 $0.110 risen by 15.79%
$148 H1 FY25 Results Presentation 27 Feb 2025 8:25AM $0.090 $0.110 risen by 22.22%
$148 H1 FY25 Results Release 27 Feb 2025 8:23AM $0.090 $0.110 risen by 22.22%
$148 H1 FY25 Appendix 4D and Half Year Report 27 Feb 2025 8:22AM $0.090 $0.110 risen by 22.22%
$148 Alcidion secures 10-year contract with NCIC 21 Feb 2025 8:24AM $0.085 $0.110 risen by 29.41%
$148 ALC FY25 Half Year Results and Investor Webcast Notification 20 Feb 2025 2:36PM $0.085 $0.110 risen by 29.41%
$148 ALC secures contract with Hywel Dda University Health Board 11 Feb 2025 8:16AM $0.077 $0.110 risen by 42.86%
$148 Q2 FY25 Quarterly Activities Report and Appendix 4C 30 Jan 2025 8:22AM $0.067 $0.110 risen by 64.18%
$148 Alcidion Q2 FY25 Results and Investor Webcast Notification 23 Jan 2025 12:28PM $0.067 $0.110 risen by 64.18%
$148 Notification of cessation of securities - ALC 20 Dec 2024 8:20AM $0.060 $0.110 risen by 83.33%
$148 Alcidion secures contract with Peninsula Health 21 Nov 2024 2:56PM $0.060 $0.110 risen by 83.33%
$148 Alcidion secures contract with NALHN 14 Nov 2024 8:27AM $0.054 $0.110 risen by 103.70%
$148 Notification regarding unquoted securities - ALC 11 Nov 2024 9:45AM $0.054 $0.110 risen by 103.70%
$148 Q1 FY25 Quarterly Activities Report and Appendix 4C 31 Oct 2024 8:22AM $0.052 $0.110 risen by 111.54%
$148 Alcidion Quarterly Results and Investor Webcast Notification 28 Oct 2024 3:00PM $0.053 $0.110 risen by 107.55%
$148 Change of Company Secretary 25 Oct 2024 3:24PM $0.055 $0.110 risen by 100%
$148 Final Director's Interest Notice 23 Oct 2024 5:12PM $0.058 $0.110 risen by 89.66%
$148 Results of 2024 Annual General Meeting 23 Oct 2024 5:10PM $0.058 $0.110 risen by 89.66%
$148 2024 Annual General Meeting Chair Address & Presentation 23 Oct 2024 2:28PM $0.057 $0.110 risen by 92.98%

76 - 100 of 592 results

Page 4 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.